These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

C3Spectra is pleased to officially announce its approval by the Federal Communications Commission (FCC) as an Automated Frequency Coordination (AFC) operator. This milestone positions the company to ...

Moving forward, any deal that is proposed must ensure that Income has the ability to provide affordable insurance coverage to Singaporeans, said Ms Stefanie Yuen-Thio, joint managing partner at TS ...

One milliliter of culture was added to 100 mL of LB with 30 μg/mL kanamycin monosulfate and incubated at 37°C and 160 r/min until the OD 600 reached 0.4–0.6. Expression was induced with 0.1 mM ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

AEP (AEP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Secondly, Stoloff considers the cuts of T-shirts by asking a few questions, such as: “Are you wearing this in the summer or layered in the winter under a blazer? Do you want a boxy, boy fit or a ...

A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk of developing cancer.